Salvatore Caruso is an Analyst at Catalio Capital Management, LP.
Prior to joining Catalio, Salvatore has held several roles in the biotechnology industry spanning R&D, business development, and technology transfer. His technical expertise is in genomics, genetic engineering, and translational gene editing therapeutics for inherited diseases.
Salvatore earned his B.S. in Chemical and Biomolecular Engineering from Johns Hopkins, his M.S. in Biomedical Engineering from Columbia University, and is concurrently pursuing his Ph.D. in Biomedical Engineering also from Columbia University.